References
Panem S, Ordonez NG, Kirstein WH, et al. C-type virus expression in systemic lupus erythematosus. N Engl J Med. 1976;295:470–5.
Gergely P, Pullmann R, Stancato C, et al. Increased prevalence of transfusion-transmitted virus and cross-reactivity with immunodominant epitopes of the HRES-1/p28 endogenous retroviral autoantigen in patients with systemic lupus erythematosus. Clin Immunol. 2005;116:124–34. doi:10.1016/j.clim.2005.04.002.
Ohshima K, Kikuchi M, Masuda Y, et al. Human T-cell leukemia virus type I associated lymphadenitis. Cancer. 1992;69:239–48. doi:10.1002/1097-0142(19920101)69:1<239::AID-CNCR2820690139>3.0.CO;2-#.
Lipka K, Tebbe B, Finckh U, et al. Absence of human T-lymphotrophic virus type I in patients with systemic lupus erythematosus. Clin Exp Dermatol. 1996;21:38–42. doi:10.1111/j.1365-2230.1996.tb00009.x.
Akimoto M, Matsushita K, Suruga Y, et al. Clinical manifestations of human T lymphotropic virus type I-infected patients with systemic lupus erythematosus. J Rheumatol. 2007;34:1841–8.
Adelman MK, Marchalonis JJ. Endogenous retrovirus in systemic lupus erythematosus: candidate lupus viruses. Clin Immunol. 2002;102:107–16. doi:10.1006/clim.2001.5153.
Suh WK, Cohen-Doyle MF, Fruh K, et al. Interaction of MHC class I molecules with the transporter associated with antigen processing. Science. 1994;264:1322–6. doi:10.1126/science.8191286.
Alexandre C, Verrie B. Four regulatory elements in the human c-fos promoter mediate transactivation by HTLV-1 Tax protein. Oncogene. 1991;6:543–51.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Shimamoto, Y., Nomura, S., Ishii, K. et al. Adult T-cell leukemia after immunosuppressive therapy for systemic lupus erythematosus. Int J Hematol 89, 128–129 (2009). https://doi.org/10.1007/s12185-008-0239-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12185-008-0239-4